BRIANNA DIPASCALE: Open Payments
NPI 1548942964 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,792 in 56 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $143 · 2025 $1,792
Food & beverage: $1,792
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $553 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $290 |
| Madrigal Pharmaceuticals | 4 | $284 |
| Janssen Biotech, Inc. | 3 | $235 |
| Ardelyx, Inc. | 1 | $112 |
| Boston Scientific Corporation | 1 | $104 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Intercept Pharmaceuticals, Inc. | 2 | $46 |
| Braintree Laboratories, Inc. | 2 | $34 |
| Exact Sciences Corporation | 1 | $26 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, SKYRIZI, ENTYVIO, IBSRELA, Axonics, EOHILIA.
Industry payments across FL — which companies pay providers there.
